Vaccine comprising a ribosomal protein extract (RPE) and optionally a Th1-promoting adjuvant

Details for Australian Patent Application No. 2009204849 (hide)

Owner Laboratorios LETI, S.L. unipersonal

Inventors Bedate, Carlos Alonso; Abanades, Daniel Ruiz; Alvarez, Manuel Soto

Agent Griffith Hack

Pub. Number AU-A-2009204849

PCT Pub. Number WO2009/090175

Priority 08100634.8 18.01.08 EP; 61/021,928 18.01.08 US

Filing date 14 January 2009

Wipo publication date 23 July 2009

International Classifications

C07K 14/44 (2006.01) Peptides having more than 20 amino acids

A61K 39/008 (2006.01) Medicinal preparations containing antigens or antibodies - Leishmania antigens

Event Publications

12 August 2010 PCT application entered the National Phase

  PCT publication WO2009/090175 Priority application(s): WO2009/090175

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009204851-Bifeprunox derivatives

2009204847-Novel piperidine-4-carboxylic acid phenyl-alkyl-amide derivatives and their use as monoamine neurotransmitter reuptake inhibitors